home / stock / verv / verv quote
Last: | $6.66 |
---|---|
Change Percent: | 0.59% |
Open: | $6.7 |
Close: | $6.66 |
High: | $6.86 |
Low: | $6.53 |
Volume: | 1,246,412 |
Last Trade Date Time: | 04/18/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$6.66 | $6.7 | $6.66 | $6.86 | $6.53 | 1,246,412 | 04-18-2024 |
$6.74 | $7.23 | $6.74 | $7.27 | $6.72 | 1,155,305 | 04-17-2024 |
$7.14 | $7.15 | $7.14 | $7.264 | $7.03 | 691,055 | 04-16-2024 |
$7.31 | $7.73 | $7.31 | $7.73 | $7.13 | 1,368,940 | 04-15-2024 |
$7.6 | $7.97 | $7.6 | $8.02 | $7.54 | 1,210,429 | 04-12-2024 |
$8.07 | $8.4 | $8.07 | $8.4 | $7.9 | 1,075,782 | 04-11-2024 |
$8.01 | $8.25 | $8.01 | $8.4 | $7.76 | 1,722,177 | 04-10-2024 |
$8.75 | $8.43 | $8.75 | $8.77 | $8.37 | 872,807 | 04-09-2024 |
$8.4 | $8.75 | $8.4 | $8.75 | $8.24 | 1,034,542 | 04-08-2024 |
$8.52 | $8.53 | $8.52 | $8.75 | $8.18 | 1,384,723 | 04-05-2024 |
$8.68 | $8.85 | $8.68 | $9.2316 | $8.64 | 1,627,995 | 04-04-2024 |
$8.71 | $8.52 | $8.71 | $8.92 | $8.173 | 2,732,135 | 04-03-2024 |
$8.32 | $8.67 | $8.32 | $9.275 | $7.3644 | 10,026,941 | 04-02-2024 |
$12.79 | $13.24 | $12.79 | $13.24 | $12.52 | 869,428 | 04-01-2024 |
$13.28 | $13.28 | $13.28 | $13.63 | $12.94 | 647,690 | 03-29-2024 |
$13.28 | $13.28 | $13.28 | $13.63 | $12.94 | 647,690 | 03-28-2024 |
$13.19 | $12.98 | $13.19 | $13.24 | $12.65 | 633,400 | 03-27-2024 |
$12.79 | $13.28 | $12.79 | $13.43 | $12.77 | 663,926 | 03-26-2024 |
$13.16 | $13.04 | $13.16 | $13.23 | $12.8 | 524,540 | 03-25-2024 |
$12.97 | $13.21 | $12.97 | $13.238 | $12.8 | 584,667 | 03-22-2024 |
News, Short Squeeze, Breakout and More Instantly...
Verve Therapeutics Inc. Company Name:
VERV Stock Symbol:
NASDAQ Market:
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, whic...
NEW YORK, NY / ACCESSWIRE / April 9, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Verve Therapeutics, Inc. ("Verve" or "the Company") (NASDAQ:VERV). Investors who purchased Verve securities are encouraged to obtain additional informat...
2024-04-06 09:50:00 ET Verve Therapeutics (NASDAQ: VERV) saw its shares crater by 36% on April 2 when it reported that a serious mishap had occurred in one of its clinical trials. Understandably, investors may now question whether the gene-editing biotech has a shot at recovering, o...